Literature DB >> 10638621

Probiotics for the hemodynamic alterations of patients with liver cirrhosis.

A De Santis, G Famularo, C De Simone.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10638621     DOI： 10.1111/j.1572-0241.2000.01726.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome.

Authors:  Na Young Lee; Sang Jun Yoon; Dae Hee Han; Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Young Lim Ham; Min Jung Kwak; Byung Yong Kim; Jeong Seok Yu; Do Yup Lee; Tae-Sik Park; Si-Hyun Park; Byoung Kook Kim; Hyun Chae Joung; In Suk Choi; Ji Taek Hong; Dong Joon Kim; Sang Hak Han; Ki Tae Suk
Journal:  Gut Microbes       Date:  2020-01-22

Review 2.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

3.  Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy.

Authors:  Qun Zhang; Fangyuan Gao; Xue Yang; Ying Hu; Yao Liu; Yixin Hou; Yuxin Li; Bingbing Zhu; Shuaishuai Niu; Yunyi Huang; Xianbo Wang
Journal:  Med Sci Monit       Date:  2020-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.